Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Activating alleles of JAK3 in acute megakaryoblastic leukemia.

Walters DK, Mercher T, Gu TL, O'Hare T, Tyner JW, Loriaux M, Goss VL, Lee KA, Eide CA, Wong MJ, Stoffregen EP, McGreevey L, Nardone J, Moore SA, Crispino J, Boggon TJ, Heinrich MC, Deininger MW, Polakiewicz RD, Gilliland DG, Druker BJ.

Cancer Cell. 2006 Jul;10(1):65-75.

2.

Mutated tyrosine kinases as therapeutic targets in myeloid leukemias.

Sattler M, Scheijen B, Weisberg E, Griffin JD.

Adv Exp Med Biol. 2003;532:121-40. Review.

PMID:
12908554
3.

JAK protein kinase inhibitors.

Thompson JE.

Drug News Perspect. 2005 Jun;18(5):305-10. Review.

PMID:
16193102
4.

Therapeutic potential of Janus kinase 3 (JAK3) inhibitors.

Cetkovic-Cvrlje M, Tibbles HE.

Curr Pharm Des. 2004;10(15):1767-84. Review.

PMID:
15180539

Supplemental Content

Support Center